Meeting on the risk assessment of the new psychoactive substances MDPV, methoxetamine, AH-7921and 25I-NBOMe

The extended Scientific Committee of the EMCDDA met on 1–2 April 2014 to examine the risk assessment by the EMCDDA on the substances MDPV, methoxetamine, AH-7921and 25I-NBOMe.

Top